nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CYP2D6—Temsirolimus—kidney cancer	0.0821	0.115	CbGbCtD
Rimonabant—CYP3A4—Everolimus—kidney cancer	0.0772	0.108	CbGbCtD
Rimonabant—CYP1A2—Pazopanib—kidney cancer	0.0523	0.0735	CbGbCtD
Rimonabant—CYP3A4—Temsirolimus—kidney cancer	0.0522	0.0733	CbGbCtD
Rimonabant—CYP2C9—Capecitabine—kidney cancer	0.0492	0.0691	CbGbCtD
Rimonabant—CYP2D6—Pazopanib—kidney cancer	0.0431	0.0605	CbGbCtD
Rimonabant—CYP1A2—Erlotinib—kidney cancer	0.0373	0.0524	CbGbCtD
Rimonabant—CYP2C9—Paclitaxel—kidney cancer	0.0308	0.0432	CbGbCtD
Rimonabant—CYP2D6—Erlotinib—kidney cancer	0.0308	0.0432	CbGbCtD
Rimonabant—CYP1A2—Sorafenib—kidney cancer	0.0304	0.0426	CbGbCtD
Rimonabant—CYP3A4—Pazopanib—kidney cancer	0.0274	0.0385	CbGbCtD
Rimonabant—CYP2C9—Sorafenib—kidney cancer	0.0273	0.0384	CbGbCtD
Rimonabant—CYP2D6—Sorafenib—kidney cancer	0.025	0.0351	CbGbCtD
Rimonabant—CYP2D6—Vinblastine—kidney cancer	0.0247	0.0347	CbGbCtD
Rimonabant—CYP3A4—Erlotinib—kidney cancer	0.0196	0.0275	CbGbCtD
Rimonabant—CYP3A4—Paclitaxel—kidney cancer	0.0179	0.0251	CbGbCtD
Rimonabant—CYP3A4—Sorafenib—kidney cancer	0.0159	0.0223	CbGbCtD
Rimonabant—CYP3A4—Vinblastine—kidney cancer	0.0157	0.0221	CbGbCtD
Rimonabant—CYP3A4—Vincristine—kidney cancer	0.0154	0.0217	CbGbCtD
Rimonabant—CYP2D6—Doxorubicin—kidney cancer	0.0152	0.0213	CbGbCtD
Rimonabant—CYP3A4—Sunitinib—kidney cancer	0.0129	0.0181	CbGbCtD
Rimonabant—CYP3A4—Doxorubicin—kidney cancer	0.00965	0.0136	CbGbCtD
Rimonabant—Nervous system disorder—Sorafenib—kidney cancer	0.000483	0.002	CcSEcCtD
Rimonabant—Mediastinal disorder—Gemcitabine—kidney cancer	0.000483	0.002	CcSEcCtD
Rimonabant—Rash—Temsirolimus—kidney cancer	0.000481	0.002	CcSEcCtD
Rimonabant—Dermatitis—Temsirolimus—kidney cancer	0.000481	0.00199	CcSEcCtD
Rimonabant—Skin disorder—Sorafenib—kidney cancer	0.000479	0.00198	CcSEcCtD
Rimonabant—Headache—Temsirolimus—kidney cancer	0.000478	0.00198	CcSEcCtD
Rimonabant—Decreased appetite—Erlotinib—kidney cancer	0.000476	0.00197	CcSEcCtD
Rimonabant—Dizziness—Pazopanib—kidney cancer	0.000476	0.00197	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000473	0.00196	CcSEcCtD
Rimonabant—Hiccups—Doxorubicin—kidney cancer	0.000472	0.00196	CcSEcCtD
Rimonabant—Fatigue—Erlotinib—kidney cancer	0.000472	0.00196	CcSEcCtD
Rimonabant—Infection—Sunitinib—kidney cancer	0.000471	0.00195	CcSEcCtD
Rimonabant—Anorexia—Sorafenib—kidney cancer	0.00047	0.00195	CcSEcCtD
Rimonabant—Sinusitis—Paclitaxel—kidney cancer	0.000469	0.00194	CcSEcCtD
Rimonabant—Gastrointestinal pain—Vinblastine—kidney cancer	0.000466	0.00193	CcSEcCtD
Rimonabant—Nervous system disorder—Sunitinib—kidney cancer	0.000465	0.00193	CcSEcCtD
Rimonabant—Gastrointestinal pain—Everolimus—kidney cancer	0.000464	0.00192	CcSEcCtD
Rimonabant—Skin disorder—Sunitinib—kidney cancer	0.000461	0.00191	CcSEcCtD
Rimonabant—Influenza—Capecitabine—kidney cancer	0.00046	0.00191	CcSEcCtD
Rimonabant—Vomiting—Pazopanib—kidney cancer	0.000457	0.0019	CcSEcCtD
Rimonabant—Rash—Pazopanib—kidney cancer	0.000453	0.00188	CcSEcCtD
Rimonabant—Nausea—Temsirolimus—kidney cancer	0.000453	0.00188	CcSEcCtD
Rimonabant—Dermatitis—Pazopanib—kidney cancer	0.000453	0.00188	CcSEcCtD
Rimonabant—Anorexia—Sunitinib—kidney cancer	0.000452	0.00187	CcSEcCtD
Rimonabant—Abdominal pain—Vinblastine—kidney cancer	0.000451	0.00187	CcSEcCtD
Rimonabant—Headache—Pazopanib—kidney cancer	0.000451	0.00187	CcSEcCtD
Rimonabant—Abdominal pain—Everolimus—kidney cancer	0.000449	0.00186	CcSEcCtD
Rimonabant—Gastrointestinal pain—Erlotinib—kidney cancer	0.000448	0.00186	CcSEcCtD
Rimonabant—Hypoaesthesia—Paclitaxel—kidney cancer	0.000446	0.00185	CcSEcCtD
Rimonabant—Infection—Dactinomycin—kidney cancer	0.000446	0.00185	CcSEcCtD
Rimonabant—Abdominal discomfort—Capecitabine—kidney cancer	0.000441	0.00183	CcSEcCtD
Rimonabant—Connective tissue disorder—Paclitaxel—kidney cancer	0.000441	0.00183	CcSEcCtD
Rimonabant—Abdominal pain—Erlotinib—kidney cancer	0.000433	0.0018	CcSEcCtD
Rimonabant—Insomnia—Sunitinib—kidney cancer	0.000429	0.00178	CcSEcCtD
Rimonabant—Decreased appetite—Sorafenib—kidney cancer	0.000428	0.00178	CcSEcCtD
Rimonabant—Anorexia—Dactinomycin—kidney cancer	0.000428	0.00177	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000427	0.00177	CcSEcCtD
Rimonabant—Nausea—Pazopanib—kidney cancer	0.000427	0.00177	CcSEcCtD
Rimonabant—Paraesthesia—Sunitinib—kidney cancer	0.000426	0.00177	CcSEcCtD
Rimonabant—Convulsion—Vincristine—kidney cancer	0.000426	0.00177	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000426	0.00176	CcSEcCtD
Rimonabant—Fatigue—Sorafenib—kidney cancer	0.000425	0.00176	CcSEcCtD
Rimonabant—Decreased appetite—Sunitinib—kidney cancer	0.000412	0.00171	CcSEcCtD
Rimonabant—Infestation NOS—Capecitabine—kidney cancer	0.00041	0.0017	CcSEcCtD
Rimonabant—Infestation—Capecitabine—kidney cancer	0.00041	0.0017	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000409	0.0017	CcSEcCtD
Rimonabant—Asthenia—Vinblastine—kidney cancer	0.000409	0.0017	CcSEcCtD
Rimonabant—Fatigue—Sunitinib—kidney cancer	0.000409	0.0017	CcSEcCtD
Rimonabant—Depression—Capecitabine—kidney cancer	0.000409	0.00169	CcSEcCtD
Rimonabant—Asthenia—Everolimus—kidney cancer	0.000407	0.00169	CcSEcCtD
Rimonabant—Angiopathy—Paclitaxel—kidney cancer	0.000407	0.00169	CcSEcCtD
Rimonabant—Mediastinal disorder—Paclitaxel—kidney cancer	0.000404	0.00168	CcSEcCtD
Rimonabant—Gastrointestinal pain—Sorafenib—kidney cancer	0.000403	0.00167	CcSEcCtD
Rimonabant—Pruritus—Everolimus—kidney cancer	0.000402	0.00167	CcSEcCtD
Rimonabant—Infection—Vincristine—kidney cancer	0.000399	0.00165	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000394	0.00163	CcSEcCtD
Rimonabant—Nervous system disorder—Vincristine—kidney cancer	0.000393	0.00163	CcSEcCtD
Rimonabant—Asthenia—Erlotinib—kidney cancer	0.000393	0.00163	CcSEcCtD
Rimonabant—Mental disorder—Paclitaxel—kidney cancer	0.000393	0.00163	CcSEcCtD
Rimonabant—Malnutrition—Paclitaxel—kidney cancer	0.00039	0.00162	CcSEcCtD
Rimonabant—Decreased appetite—Dactinomycin—kidney cancer	0.00039	0.00162	CcSEcCtD
Rimonabant—Diarrhoea—Vinblastine—kidney cancer	0.00039	0.00162	CcSEcCtD
Rimonabant—Abdominal pain—Sorafenib—kidney cancer	0.00039	0.00162	CcSEcCtD
Rimonabant—Diarrhoea—Everolimus—kidney cancer	0.000389	0.00161	CcSEcCtD
Rimonabant—Gastrointestinal pain—Sunitinib—kidney cancer	0.000388	0.00161	CcSEcCtD
Rimonabant—Hyperhidrosis—Vincristine—kidney cancer	0.000388	0.00161	CcSEcCtD
Rimonabant—Pruritus—Erlotinib—kidney cancer	0.000388	0.00161	CcSEcCtD
Rimonabant—Fatigue—Dactinomycin—kidney cancer	0.000387	0.0016	CcSEcCtD
Rimonabant—Tension—Paclitaxel—kidney cancer	0.000383	0.00159	CcSEcCtD
Rimonabant—Anorexia—Vincristine—kidney cancer	0.000382	0.00159	CcSEcCtD
Rimonabant—Nervousness—Paclitaxel—kidney cancer	0.000379	0.00157	CcSEcCtD
Rimonabant—Infection—Gemcitabine—kidney cancer	0.000378	0.00157	CcSEcCtD
Rimonabant—Dizziness—Vinblastine—kidney cancer	0.000377	0.00156	CcSEcCtD
Rimonabant—Dizziness—Everolimus—kidney cancer	0.000376	0.00156	CcSEcCtD
Rimonabant—Muscle spasms—Paclitaxel—kidney cancer	0.000375	0.00156	CcSEcCtD
Rimonabant—Abdominal pain—Sunitinib—kidney cancer	0.000375	0.00155	CcSEcCtD
Rimonabant—Diarrhoea—Erlotinib—kidney cancer	0.000375	0.00155	CcSEcCtD
Rimonabant—Nervous system disorder—Gemcitabine—kidney cancer	0.000373	0.00155	CcSEcCtD
Rimonabant—Skin disorder—Gemcitabine—kidney cancer	0.00037	0.00153	CcSEcCtD
Rimonabant—Hyperhidrosis—Gemcitabine—kidney cancer	0.000368	0.00153	CcSEcCtD
Rimonabant—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000367	0.00152	CcSEcCtD
Rimonabant—Hot flush—Doxorubicin—kidney cancer	0.000367	0.00152	CcSEcCtD
Rimonabant—Hypoaesthesia—Capecitabine—kidney cancer	0.000366	0.00152	CcSEcCtD
Rimonabant—Tremor—Paclitaxel—kidney cancer	0.000366	0.00152	CcSEcCtD
Rimonabant—Menopausal symptoms—Doxorubicin—kidney cancer	0.000363	0.00151	CcSEcCtD
Rimonabant—Insomnia—Vincristine—kidney cancer	0.000363	0.0015	CcSEcCtD
Rimonabant—Anorexia—Gemcitabine—kidney cancer	0.000363	0.0015	CcSEcCtD
Rimonabant—Vomiting—Vinblastine—kidney cancer	0.000362	0.0015	CcSEcCtD
Rimonabant—Dizziness—Erlotinib—kidney cancer	0.000362	0.0015	CcSEcCtD
Rimonabant—Connective tissue disorder—Capecitabine—kidney cancer	0.000362	0.0015	CcSEcCtD
Rimonabant—Vomiting—Everolimus—kidney cancer	0.000361	0.0015	CcSEcCtD
Rimonabant—Paraesthesia—Vincristine—kidney cancer	0.00036	0.00149	CcSEcCtD
Rimonabant—Rash—Everolimus—kidney cancer	0.000358	0.00148	CcSEcCtD
Rimonabant—Dermatitis—Everolimus—kidney cancer	0.000358	0.00148	CcSEcCtD
Rimonabant—Headache—Vinblastine—kidney cancer	0.000357	0.00148	CcSEcCtD
Rimonabant—Headache—Everolimus—kidney cancer	0.000356	0.00147	CcSEcCtD
Rimonabant—Abdominal pain—Dactinomycin—kidney cancer	0.000355	0.00147	CcSEcCtD
Rimonabant—Asthenia—Sorafenib—kidney cancer	0.000354	0.00147	CcSEcCtD
Rimonabant—Hypoglycaemia—Doxorubicin—kidney cancer	0.000351	0.00146	CcSEcCtD
Rimonabant—Lethargy—Doxorubicin—kidney cancer	0.00035	0.00145	CcSEcCtD
Rimonabant—Decreased appetite—Vincristine—kidney cancer	0.000349	0.00145	CcSEcCtD
Rimonabant—Pruritus—Sorafenib—kidney cancer	0.000349	0.00145	CcSEcCtD
Rimonabant—Vomiting—Erlotinib—kidney cancer	0.000348	0.00144	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Vincristine—kidney cancer	0.000346	0.00144	CcSEcCtD
Rimonabant—Fatigue—Vincristine—kidney cancer	0.000346	0.00143	CcSEcCtD
Rimonabant—Rash—Erlotinib—kidney cancer	0.000345	0.00143	CcSEcCtD
Rimonabant—Dermatitis—Erlotinib—kidney cancer	0.000345	0.00143	CcSEcCtD
Rimonabant—Insomnia—Gemcitabine—kidney cancer	0.000344	0.00143	CcSEcCtD
Rimonabant—Headache—Erlotinib—kidney cancer	0.000343	0.00142	CcSEcCtD
Rimonabant—Paraesthesia—Gemcitabine—kidney cancer	0.000342	0.00142	CcSEcCtD
Rimonabant—Asthenia—Sunitinib—kidney cancer	0.00034	0.00141	CcSEcCtD
Rimonabant—Nausea—Vinblastine—kidney cancer	0.000339	0.0014	CcSEcCtD
Rimonabant—Convulsion—Paclitaxel—kidney cancer	0.000338	0.0014	CcSEcCtD
Rimonabant—Nausea—Everolimus—kidney cancer	0.000337	0.0014	CcSEcCtD
Rimonabant—Diarrhoea—Sorafenib—kidney cancer	0.000337	0.0014	CcSEcCtD
Rimonabant—Pruritus—Sunitinib—kidney cancer	0.000336	0.00139	CcSEcCtD
Rimonabant—Angiopathy—Capecitabine—kidney cancer	0.000334	0.00138	CcSEcCtD
Rimonabant—Mediastinal disorder—Capecitabine—kidney cancer	0.000332	0.00138	CcSEcCtD
Rimonabant—Anxiety—Paclitaxel—kidney cancer	0.000331	0.00137	CcSEcCtD
Rimonabant—Decreased appetite—Gemcitabine—kidney cancer	0.000331	0.00137	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.00033	0.00137	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000329	0.00136	CcSEcCtD
Rimonabant—Fatigue—Gemcitabine—kidney cancer	0.000328	0.00136	CcSEcCtD
Rimonabant—Gastrointestinal pain—Vincristine—kidney cancer	0.000328	0.00136	CcSEcCtD
Rimonabant—Dizziness—Sorafenib—kidney cancer	0.000326	0.00135	CcSEcCtD
Rimonabant—Nausea—Erlotinib—kidney cancer	0.000325	0.00135	CcSEcCtD
Rimonabant—Dry mouth—Paclitaxel—kidney cancer	0.000325	0.00135	CcSEcCtD
Rimonabant—Mood swings—Doxorubicin—kidney cancer	0.000325	0.00135	CcSEcCtD
Rimonabant—Diarrhoea—Sunitinib—kidney cancer	0.000325	0.00135	CcSEcCtD
Rimonabant—Mental disorder—Capecitabine—kidney cancer	0.000322	0.00134	CcSEcCtD
Rimonabant—Asthenia—Dactinomycin—kidney cancer	0.000322	0.00134	CcSEcCtD
Rimonabant—Malnutrition—Capecitabine—kidney cancer	0.00032	0.00133	CcSEcCtD
Rimonabant—Abdominal pain—Vincristine—kidney cancer	0.000317	0.00131	CcSEcCtD
Rimonabant—Infection—Paclitaxel—kidney cancer	0.000317	0.00131	CcSEcCtD
Rimonabant—Dizziness—Sunitinib—kidney cancer	0.000314	0.0013	CcSEcCtD
Rimonabant—Vomiting—Sorafenib—kidney cancer	0.000313	0.0013	CcSEcCtD
Rimonabant—Nervous system disorder—Paclitaxel—kidney cancer	0.000312	0.0013	CcSEcCtD
Rimonabant—Rash—Sorafenib—kidney cancer	0.000311	0.00129	CcSEcCtD
Rimonabant—Dermatitis—Sorafenib—kidney cancer	0.000311	0.00129	CcSEcCtD
Rimonabant—Skin disorder—Paclitaxel—kidney cancer	0.00031	0.00128	CcSEcCtD
Rimonabant—Headache—Sorafenib—kidney cancer	0.000309	0.00128	CcSEcCtD
Rimonabant—Muscle spasms—Capecitabine—kidney cancer	0.000308	0.00128	CcSEcCtD
Rimonabant—Hyperhidrosis—Paclitaxel—kidney cancer	0.000308	0.00128	CcSEcCtD
Rimonabant—Diarrhoea—Dactinomycin—kidney cancer	0.000307	0.00127	CcSEcCtD
Rimonabant—Anorexia—Paclitaxel—kidney cancer	0.000304	0.00126	CcSEcCtD
Rimonabant—Vomiting—Sunitinib—kidney cancer	0.000302	0.00125	CcSEcCtD
Rimonabant—Tremor—Capecitabine—kidney cancer	0.0003	0.00124	CcSEcCtD
Rimonabant—Rash—Sunitinib—kidney cancer	0.000299	0.00124	CcSEcCtD
Rimonabant—Dermatitis—Sunitinib—kidney cancer	0.000299	0.00124	CcSEcCtD
Rimonabant—Headache—Sunitinib—kidney cancer	0.000297	0.00123	CcSEcCtD
Rimonabant—Influenza—Doxorubicin—kidney cancer	0.000296	0.00123	CcSEcCtD
Rimonabant—Nausea—Sorafenib—kidney cancer	0.000293	0.00121	CcSEcCtD
Rimonabant—Insomnia—Paclitaxel—kidney cancer	0.000288	0.00119	CcSEcCtD
Rimonabant—Asthenia—Vincristine—kidney cancer	0.000288	0.00119	CcSEcCtD
Rimonabant—Paraesthesia—Paclitaxel—kidney cancer	0.000286	0.00119	CcSEcCtD
Rimonabant—Vomiting—Dactinomycin—kidney cancer	0.000285	0.00118	CcSEcCtD
Rimonabant—Rash—Dactinomycin—kidney cancer	0.000283	0.00117	CcSEcCtD
Rimonabant—Nausea—Sunitinib—kidney cancer	0.000282	0.00117	CcSEcCtD
Rimonabant—Decreased appetite—Paclitaxel—kidney cancer	0.000277	0.00115	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000275	0.00114	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000275	0.00114	CcSEcCtD
Rimonabant—Fatigue—Paclitaxel—kidney cancer	0.000275	0.00114	CcSEcCtD
Rimonabant—Diarrhoea—Vincristine—kidney cancer	0.000274	0.00114	CcSEcCtD
Rimonabant—Asthenia—Gemcitabine—kidney cancer	0.000273	0.00113	CcSEcCtD
Rimonabant—Anxiety—Capecitabine—kidney cancer	0.000272	0.00113	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000271	0.00112	CcSEcCtD
Rimonabant—Pruritus—Gemcitabine—kidney cancer	0.000269	0.00112	CcSEcCtD
Rimonabant—Dry mouth—Capecitabine—kidney cancer	0.000267	0.00111	CcSEcCtD
Rimonabant—Nausea—Dactinomycin—kidney cancer	0.000267	0.00111	CcSEcCtD
Rimonabant—Dizziness—Vincristine—kidney cancer	0.000265	0.0011	CcSEcCtD
Rimonabant—Infestation—Doxorubicin—kidney cancer	0.000264	0.0011	CcSEcCtD
Rimonabant—Infestation NOS—Doxorubicin—kidney cancer	0.000264	0.0011	CcSEcCtD
Rimonabant—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000261	0.00108	CcSEcCtD
Rimonabant—Diarrhoea—Gemcitabine—kidney cancer	0.00026	0.00108	CcSEcCtD
Rimonabant—Infection—Capecitabine—kidney cancer	0.00026	0.00108	CcSEcCtD
Rimonabant—Nervous system disorder—Capecitabine—kidney cancer	0.000256	0.00106	CcSEcCtD
Rimonabant—Vomiting—Vincristine—kidney cancer	0.000255	0.00106	CcSEcCtD
Rimonabant—Skin disorder—Capecitabine—kidney cancer	0.000254	0.00105	CcSEcCtD
Rimonabant—Rash—Vincristine—kidney cancer	0.000253	0.00105	CcSEcCtD
Rimonabant—Hyperhidrosis—Capecitabine—kidney cancer	0.000253	0.00105	CcSEcCtD
Rimonabant—Dermatitis—Vincristine—kidney cancer	0.000253	0.00105	CcSEcCtD
Rimonabant—Abdominal pain—Paclitaxel—kidney cancer	0.000252	0.00104	CcSEcCtD
Rimonabant—Headache—Vincristine—kidney cancer	0.000251	0.00104	CcSEcCtD
Rimonabant—Anorexia—Capecitabine—kidney cancer	0.000249	0.00103	CcSEcCtD
Rimonabant—Sinusitis—Doxorubicin—kidney cancer	0.000248	0.00103	CcSEcCtD
Rimonabant—Vomiting—Gemcitabine—kidney cancer	0.000242	0.001	CcSEcCtD
Rimonabant—Rash—Gemcitabine—kidney cancer	0.00024	0.000995	CcSEcCtD
Rimonabant—Dermatitis—Gemcitabine—kidney cancer	0.00024	0.000994	CcSEcCtD
Rimonabant—Headache—Gemcitabine—kidney cancer	0.000238	0.000988	CcSEcCtD
Rimonabant—Nausea—Vincristine—kidney cancer	0.000238	0.000988	CcSEcCtD
Rimonabant—Insomnia—Capecitabine—kidney cancer	0.000237	0.00098	CcSEcCtD
Rimonabant—Hypoaesthesia—Doxorubicin—kidney cancer	0.000236	0.000979	CcSEcCtD
Rimonabant—Paraesthesia—Capecitabine—kidney cancer	0.000235	0.000973	CcSEcCtD
Rimonabant—Connective tissue disorder—Doxorubicin—kidney cancer	0.000233	0.000966	CcSEcCtD
Rimonabant—Asthenia—Paclitaxel—kidney cancer	0.000229	0.000948	CcSEcCtD
Rimonabant—Decreased appetite—Capecitabine—kidney cancer	0.000227	0.000942	CcSEcCtD
Rimonabant—Nausea—Gemcitabine—kidney cancer	0.000226	0.000937	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000226	0.000936	CcSEcCtD
Rimonabant—Fatigue—Capecitabine—kidney cancer	0.000225	0.000935	CcSEcCtD
Rimonabant—Pruritus—Paclitaxel—kidney cancer	0.000225	0.000935	CcSEcCtD
Rimonabant—Diarrhoea—Paclitaxel—kidney cancer	0.000218	0.000904	CcSEcCtD
Rimonabant—Angiopathy—Doxorubicin—kidney cancer	0.000215	0.000892	CcSEcCtD
Rimonabant—Gastrointestinal pain—Capecitabine—kidney cancer	0.000214	0.000886	CcSEcCtD
Rimonabant—Mediastinal disorder—Doxorubicin—kidney cancer	0.000214	0.000886	CcSEcCtD
Rimonabant—Dizziness—Paclitaxel—kidney cancer	0.000211	0.000874	CcSEcCtD
Rimonabant—Mental disorder—Doxorubicin—kidney cancer	0.000208	0.000862	CcSEcCtD
Rimonabant—Abdominal pain—Capecitabine—kidney cancer	0.000207	0.000857	CcSEcCtD
Rimonabant—Malnutrition—Doxorubicin—kidney cancer	0.000207	0.000856	CcSEcCtD
Rimonabant—Tension—Doxorubicin—kidney cancer	0.000203	0.00084	CcSEcCtD
Rimonabant—Vomiting—Paclitaxel—kidney cancer	0.000203	0.00084	CcSEcCtD
Rimonabant—Rash—Paclitaxel—kidney cancer	0.000201	0.000833	CcSEcCtD
Rimonabant—Dermatitis—Paclitaxel—kidney cancer	0.000201	0.000832	CcSEcCtD
Rimonabant—Nervousness—Doxorubicin—kidney cancer	0.000201	0.000832	CcSEcCtD
Rimonabant—Headache—Paclitaxel—kidney cancer	0.0002	0.000828	CcSEcCtD
Rimonabant—Muscle spasms—Doxorubicin—kidney cancer	0.000199	0.000823	CcSEcCtD
Rimonabant—Nausea—Paclitaxel—kidney cancer	0.000189	0.000785	CcSEcCtD
Rimonabant—Asthenia—Capecitabine—kidney cancer	0.000188	0.000778	CcSEcCtD
Rimonabant—Pruritus—Capecitabine—kidney cancer	0.000185	0.000767	CcSEcCtD
Rimonabant—Convulsion—Doxorubicin—kidney cancer	0.000179	0.000742	CcSEcCtD
Rimonabant—Diarrhoea—Capecitabine—kidney cancer	0.000179	0.000742	CcSEcCtD
Rimonabant—Anxiety—Doxorubicin—kidney cancer	0.000175	0.000726	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000175	0.000724	CcSEcCtD
Rimonabant—Dizziness—Capecitabine—kidney cancer	0.000173	0.000717	CcSEcCtD
Rimonabant—Dry mouth—Doxorubicin—kidney cancer	0.000172	0.000713	CcSEcCtD
Rimonabant—Infection—Doxorubicin—kidney cancer	0.000167	0.000694	CcSEcCtD
Rimonabant—Vomiting—Capecitabine—kidney cancer	0.000166	0.000689	CcSEcCtD
Rimonabant—Nervous system disorder—Doxorubicin—kidney cancer	0.000165	0.000685	CcSEcCtD
Rimonabant—Rash—Capecitabine—kidney cancer	0.000165	0.000683	CcSEcCtD
Rimonabant—Dermatitis—Capecitabine—kidney cancer	0.000165	0.000683	CcSEcCtD
Rimonabant—Headache—Capecitabine—kidney cancer	0.000164	0.000679	CcSEcCtD
Rimonabant—Skin disorder—Doxorubicin—kidney cancer	0.000164	0.000679	CcSEcCtD
Rimonabant—Hyperhidrosis—Doxorubicin—kidney cancer	0.000163	0.000676	CcSEcCtD
Rimonabant—Anorexia—Doxorubicin—kidney cancer	0.000161	0.000666	CcSEcCtD
Rimonabant—Nausea—Capecitabine—kidney cancer	0.000155	0.000644	CcSEcCtD
Rimonabant—Insomnia—Doxorubicin—kidney cancer	0.000152	0.000632	CcSEcCtD
Rimonabant—Paraesthesia—Doxorubicin—kidney cancer	0.000151	0.000627	CcSEcCtD
Rimonabant—Decreased appetite—Doxorubicin—kidney cancer	0.000147	0.000607	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000146	0.000603	CcSEcCtD
Rimonabant—Fatigue—Doxorubicin—kidney cancer	0.000145	0.000602	CcSEcCtD
Rimonabant—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000138	0.000571	CcSEcCtD
Rimonabant—Abdominal pain—Doxorubicin—kidney cancer	0.000133	0.000552	CcSEcCtD
Rimonabant—Asthenia—Doxorubicin—kidney cancer	0.000121	0.000501	CcSEcCtD
Rimonabant—Pruritus—Doxorubicin—kidney cancer	0.000119	0.000494	CcSEcCtD
Rimonabant—Diarrhoea—Doxorubicin—kidney cancer	0.000115	0.000478	CcSEcCtD
Rimonabant—Dizziness—Doxorubicin—kidney cancer	0.000111	0.000462	CcSEcCtD
Rimonabant—Vomiting—Doxorubicin—kidney cancer	0.000107	0.000444	CcSEcCtD
Rimonabant—Rash—Doxorubicin—kidney cancer	0.000106	0.000441	CcSEcCtD
Rimonabant—Dermatitis—Doxorubicin—kidney cancer	0.000106	0.00044	CcSEcCtD
Rimonabant—Headache—Doxorubicin—kidney cancer	0.000106	0.000438	CcSEcCtD
Rimonabant—Nausea—Doxorubicin—kidney cancer	0.0001	0.000415	CcSEcCtD
Rimonabant—CYP2D6—Biological oxidations—GSTM1—kidney cancer	5e-05	0.00107	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	4.97e-05	0.00106	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—GSTM1—kidney cancer	4.96e-05	0.00106	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—IL2—kidney cancer	4.95e-05	0.00106	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	4.93e-05	0.00105	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	4.89e-05	0.00104	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	4.87e-05	0.00104	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—PTGS1—kidney cancer	4.81e-05	0.00103	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	4.74e-05	0.00101	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—HIF1A—kidney cancer	4.71e-05	0.00101	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TSC2—kidney cancer	4.7e-05	0.001	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	4.7e-05	0.001	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	4.68e-05	0.000999	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IGF2—kidney cancer	4.65e-05	0.000992	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	4.64e-05	0.00099	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CDKN2B—kidney cancer	4.63e-05	0.000988	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—GSTP1—kidney cancer	4.61e-05	0.000985	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	4.6e-05	0.000981	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	4.55e-05	0.000971	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—KDR—kidney cancer	4.51e-05	0.000963	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IGF1R—kidney cancer	4.49e-05	0.000959	CbGpPWpGaD
Rimonabant—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.35e-05	0.000929	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—RAF1—kidney cancer	4.33e-05	0.000925	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—IL2—kidney cancer	4.27e-05	0.000913	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—GSTM1—kidney cancer	4.24e-05	0.000905	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	4.18e-05	0.000893	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ACY1—kidney cancer	4.17e-05	0.000891	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—KIT—kidney cancer	4.15e-05	0.000887	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—APC—kidney cancer	4.15e-05	0.000887	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ACY1—kidney cancer	4.14e-05	0.000883	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	4.02e-05	0.000858	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—MAPK3—kidney cancer	3.98e-05	0.000849	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	3.96e-05	0.000846	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—POMC—kidney cancer	3.95e-05	0.000844	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—BRAF—kidney cancer	3.9e-05	0.000834	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—IL2—kidney cancer	3.88e-05	0.000829	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—MAPK1—kidney cancer	3.78e-05	0.000808	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HIF1A—kidney cancer	3.7e-05	0.00079	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TSC2—kidney cancer	3.69e-05	0.000788	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—PIK3CA—kidney cancer	3.62e-05	0.000772	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—KRAS—kidney cancer	3.57e-05	0.000763	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—GSTP1—kidney cancer	3.56e-05	0.00076	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PDHB—kidney cancer	3.55e-05	0.000757	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—KDR—kidney cancer	3.54e-05	0.000755	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—POMC—kidney cancer	3.54e-05	0.000755	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ACY1—kidney cancer	3.53e-05	0.000755	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.53e-05	0.000753	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PDHB—kidney cancer	3.52e-05	0.000751	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	3.51e-05	0.00075	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—POMC—kidney cancer	3.51e-05	0.000749	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CCBL1—kidney cancer	3.33e-05	0.000712	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CCBL1—kidney cancer	3.31e-05	0.000706	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—PIK3CA—kidney cancer	3.28e-05	0.000701	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—GSTM1—kidney cancer	3.27e-05	0.000698	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—RAF1—kidney cancer	3.26e-05	0.000696	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—APC—kidney cancer	3.26e-05	0.000696	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—KIT—kidney cancer	3.26e-05	0.000696	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—RELA—kidney cancer	3.24e-05	0.000693	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	3.23e-05	0.000689	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—ERBB2—kidney cancer	3.22e-05	0.000689	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MTOR—kidney cancer	3.18e-05	0.00068	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—MAPK3—kidney cancer	3.12e-05	0.000666	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—POMC—kidney cancer	3.1e-05	0.000662	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	3.1e-05	0.000662	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—BRAF—kidney cancer	3.06e-05	0.000654	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	3.06e-05	0.000653	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.01e-05	0.000644	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PDHB—kidney cancer	3e-05	0.000642	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—POMC—kidney cancer	3e-05	0.00064	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.99e-05	0.000638	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CDKN1B—kidney cancer	2.99e-05	0.000638	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—MAPK1—kidney cancer	2.97e-05	0.000634	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IL2—kidney cancer	2.92e-05	0.000624	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GLIPR1—kidney cancer	2.89e-05	0.000617	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PPAT—kidney cancer	2.89e-05	0.000617	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GLIPR1—kidney cancer	2.87e-05	0.000612	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PPAT—kidney cancer	2.87e-05	0.000612	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CCND1—kidney cancer	2.85e-05	0.000608	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—JUN—kidney cancer	2.84e-05	0.000607	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—PIK3CA—kidney cancer	2.84e-05	0.000606	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.83e-05	0.000604	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CCBL1—kidney cancer	2.83e-05	0.000603	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CTNNB1—kidney cancer	2.82e-05	0.000602	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—KRAS—kidney cancer	2.8e-05	0.000599	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.8e-05	0.000598	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PTEN—kidney cancer	2.75e-05	0.000587	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ACY1—kidney cancer	2.73e-05	0.000582	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—APRT—kidney cancer	2.69e-05	0.000574	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—FH—kidney cancer	2.69e-05	0.000574	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—FH—kidney cancer	2.66e-05	0.000569	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—APRT—kidney cancer	2.66e-05	0.000569	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.6e-05	0.000556	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—PIK3CA—kidney cancer	2.58e-05	0.00055	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—RAF1—kidney cancer	2.56e-05	0.000546	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.55e-05	0.000546	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—RELA—kidney cancer	2.55e-05	0.000544	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—ERBB2—kidney cancer	2.53e-05	0.00054	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GPC3—kidney cancer	2.53e-05	0.00054	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GPC3—kidney cancer	2.51e-05	0.000535	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MTOR—kidney cancer	2.5e-05	0.000533	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—VEGFA—kidney cancer	2.48e-05	0.00053	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CA2—kidney cancer	2.46e-05	0.000525	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PPAT—kidney cancer	2.45e-05	0.000523	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GLIPR1—kidney cancer	2.45e-05	0.000523	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CA2—kidney cancer	2.44e-05	0.00052	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.42e-05	0.000516	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ALAD—kidney cancer	2.4e-05	0.000512	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.39e-05	0.000511	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ALAD—kidney cancer	2.38e-05	0.000507	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MAPK3—kidney cancer	2.35e-05	0.000502	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CDKN1B—kidney cancer	2.34e-05	0.0005	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ST3GAL2—kidney cancer	2.34e-05	0.000499	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PDHB—kidney cancer	2.32e-05	0.000495	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ST3GAL2—kidney cancer	2.32e-05	0.000495	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—POMC—kidney cancer	2.31e-05	0.000494	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL2—kidney cancer	2.29e-05	0.00049	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ALDH1A1—kidney cancer	2.29e-05	0.000488	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MYC—kidney cancer	2.29e-05	0.000488	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—APRT—kidney cancer	2.28e-05	0.000486	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—FH—kidney cancer	2.28e-05	0.000486	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ALDH1A1—kidney cancer	2.27e-05	0.000484	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MAPK1—kidney cancer	2.24e-05	0.000477	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CCND1—kidney cancer	2.24e-05	0.000477	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—JUN—kidney cancer	2.23e-05	0.000476	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.23e-05	0.000475	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CTNNB1—kidney cancer	2.21e-05	0.000473	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PGK1—kidney cancer	2.19e-05	0.000468	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SLC5A3—kidney cancer	2.19e-05	0.000468	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CCBL1—kidney cancer	2.18e-05	0.000466	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PGK1—kidney cancer	2.17e-05	0.000464	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SLC5A3—kidney cancer	2.17e-05	0.000464	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PTEN—kidney cancer	2.16e-05	0.000461	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—LDHB—kidney cancer	2.15e-05	0.000459	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GPC3—kidney cancer	2.14e-05	0.000457	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—LDHB—kidney cancer	2.13e-05	0.000455	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—KRAS—kidney cancer	2.11e-05	0.000451	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CA2—kidney cancer	2.08e-05	0.000445	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ALAD—kidney cancer	2.03e-05	0.000433	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.98e-05	0.000423	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—VEGFA—kidney cancer	1.95e-05	0.000416	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PIK3CA—kidney cancer	1.94e-05	0.000414	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.94e-05	0.000413	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.89e-05	0.000404	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PPAT—kidney cancer	1.89e-05	0.000404	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TP53—kidney cancer	1.88e-05	0.000401	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CA9—kidney cancer	1.86e-05	0.000398	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PGK1—kidney cancer	1.86e-05	0.000396	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.86e-05	0.000396	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CA9—kidney cancer	1.85e-05	0.000394	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MAPK3—kidney cancer	1.84e-05	0.000394	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—LDHB—kidney cancer	1.82e-05	0.000389	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.81e-05	0.000386	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MYC—kidney cancer	1.79e-05	0.000383	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—FH—kidney cancer	1.76e-05	0.000375	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—APRT—kidney cancer	1.76e-05	0.000375	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MAPK1—kidney cancer	1.75e-05	0.000375	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—KRAS—kidney cancer	1.66e-05	0.000354	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GPC3—kidney cancer	1.65e-05	0.000353	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CA2—kidney cancer	1.61e-05	0.000343	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CRABP1—kidney cancer	1.58e-05	0.000338	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CA9—kidney cancer	1.58e-05	0.000337	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CRABP1—kidney cancer	1.57e-05	0.000335	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ALAD—kidney cancer	1.57e-05	0.000335	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.54e-05	0.000329	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.53e-05	0.000326	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PIK3CA—kidney cancer	1.52e-05	0.000325	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.49e-05	0.000319	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ITPR2—kidney cancer	1.47e-05	0.000315	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TP53—kidney cancer	1.47e-05	0.000314	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ITPR2—kidney cancer	1.46e-05	0.000312	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.43e-05	0.000306	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PGK1—kidney cancer	1.43e-05	0.000306	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—LDHB—kidney cancer	1.4e-05	0.0003	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.35e-05	0.000287	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTT1—kidney cancer	1.34e-05	0.000287	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ACHE—kidney cancer	1.34e-05	0.000287	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CRABP1—kidney cancer	1.34e-05	0.000287	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ACHE—kidney cancer	1.33e-05	0.000284	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTT1—kidney cancer	1.33e-05	0.000284	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SCARB1—kidney cancer	1.27e-05	0.000271	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SCARB1—kidney cancer	1.26e-05	0.000269	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTGS1—kidney cancer	1.26e-05	0.000269	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ITPR2—kidney cancer	1.25e-05	0.000266	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTGS1—kidney cancer	1.25e-05	0.000266	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PSMD7—kidney cancer	1.23e-05	0.000264	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PSMD7—kidney cancer	1.22e-05	0.000261	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CA9—kidney cancer	1.22e-05	0.00026	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—BCHE—kidney cancer	1.17e-05	0.00025	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—BCHE—kidney cancer	1.16e-05	0.000248	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.16e-05	0.000247	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.15e-05	0.000246	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.15e-05	0.000245	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTT1—kidney cancer	1.14e-05	0.000243	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ACHE—kidney cancer	1.14e-05	0.000243	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.12e-05	0.000238	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.11e-05	0.000236	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SCARB1—kidney cancer	1.08e-05	0.00023	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.07e-05	0.000229	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTGS1—kidney cancer	1.07e-05	0.000228	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PSMD7—kidney cancer	1.05e-05	0.000223	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CRABP1—kidney cancer	1.04e-05	0.000221	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—BCHE—kidney cancer	9.91e-06	0.000212	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SLC5A5—kidney cancer	9.79e-06	0.000209	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ITPR2—kidney cancer	9.63e-06	0.000206	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SLC2A1—kidney cancer	9.46e-06	0.000202	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.36e-06	0.0002	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTP1—kidney cancer	9.31e-06	0.000199	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTP1—kidney cancer	9.23e-06	0.000197	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.17e-06	0.000196	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ABCB1—kidney cancer	8.81e-06	0.000188	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTT1—kidney cancer	8.78e-06	0.000188	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ACHE—kidney cancer	8.78e-06	0.000188	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ABCB1—kidney cancer	8.74e-06	0.000187	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTM1—kidney cancer	8.55e-06	0.000183	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTM1—kidney cancer	8.48e-06	0.000181	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SCARB1—kidney cancer	8.31e-06	0.000178	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTGS1—kidney cancer	8.23e-06	0.000176	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP1A1—kidney cancer	8.11e-06	0.000173	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PSMD7—kidney cancer	8.07e-06	0.000172	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP1A1—kidney cancer	8.04e-06	0.000172	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8e-06	0.000171	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTP1—kidney cancer	7.89e-06	0.000168	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—BCHE—kidney cancer	7.65e-06	0.000163	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC5A5—kidney cancer	7.56e-06	0.000161	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ABCB1—kidney cancer	7.47e-06	0.000159	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC2A1—kidney cancer	7.3e-06	0.000156	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTM1—kidney cancer	7.25e-06	0.000155	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP1A1—kidney cancer	6.87e-06	0.000147	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.61e-06	0.000141	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTP1—kidney cancer	6.09e-06	0.00013	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—POMC—kidney cancer	6.05e-06	0.000129	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—POMC—kidney cancer	5.99e-06	0.000128	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ABCB1—kidney cancer	5.76e-06	0.000123	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.64e-06	0.000121	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTM1—kidney cancer	5.59e-06	0.000119	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP1A1—kidney cancer	5.3e-06	0.000113	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—POMC—kidney cancer	5.12e-06	0.000109	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTGS2—kidney cancer	4.82e-06	0.000103	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTGS2—kidney cancer	4.78e-06	0.000102	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTEN—kidney cancer	4.21e-06	8.98e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTEN—kidney cancer	4.17e-06	8.9e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTGS2—kidney cancer	4.09e-06	8.73e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—POMC—kidney cancer	3.95e-06	8.44e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTEN—kidney cancer	3.56e-06	7.61e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTGS2—kidney cancer	3.15e-06	6.73e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CA—kidney cancer	2.97e-06	6.34e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CA—kidney cancer	2.94e-06	6.28e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTEN—kidney cancer	2.75e-06	5.87e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CA—kidney cancer	2.51e-06	5.37e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.94e-06	4.14e-05	CbGpPWpGaD
